Immunome Research (ISSN: 1745-7580) indexing in PubMed and many other popular indexing services, came to life in 2005 through BioMed Central
Henderson, NV (PRWEB) August 08, 2013
OMICS Group Incorporation, a scientific organization that drives the progress of research through scholarly Open Access Journals, today announced a landmark agreement with Nikolai Petrovsky Publishing for acquisition of Immunome Research, an Open access, Peer reviewed, interdisciplinary journal.
Immunome Research (ISSN: 1745-7580) indexing in PubMed and many other popular indexing services, came to life in 2005 through BioMed Central, bringing the prime focus in the nascent field of Immunomics, which includes traditional wet lab immunology research approaches with the new sciences of Genomics, Proteomics, and Bioinformatics as well as mathematical modelling.
Recently in June 2013, Dr. Srinubabu Gedela, CEO, OMICS Publishing Group and OMICS Group Conferences signed an agreement with Dr. Nikolai Petrovsky, Proprietor, Nikolai Petrovsky Publishing for acquiring Immunome Research Journal – adding one more journal to their list of 300 and more peer-reviewed Open Access Journals.
Dr. Srinubabu Gedela says, "This acquisition will ensure that the journal continues to promote the findings of contemporary research in the exciting and challenging field of Immunomics. We will do our best to reshape IRJ into a high-quality top open access journal. In order to meet the goal, we have created the Advisory Editorial Board, consisting of world-class, excellent and experienced professors and researchers in the field of immunomics. We have also implemented a very efficient Editorial managing system for streamlining the whole process from manuscript submission to online publication for authors.”
More about OMICS Group:
OMICS Group Incorporation was founded by Dr. Srinubabu Gedela, with a mission of making the scientific information Open Access. OMICS Group hosts over 300 leading-edge peer reviewed Open Access journals and has organised over 100 scientific conferences all over the world. Success of the same can be attributed to the strong editorial board which consist of over 20000 eminent personalities and about 2 million readers. OMICS Group has started new initiatives to fulfil its mission of making healthcare information open access: SciTechnol, E-Books, Scholars Central, Clinical and Expert Database, Bio safety Protocols, and E-BABE.
More about Nikolai Petrovsky:
Dr. Nikolai Petrovsky, Proprietor, Nikolai Petrovsky Publishing is a director of endocrinology at flinders medical center with a conjoint position as professor of medicine at flinders University. He is also vice-president and secretary-general of the international immunomics society. Active in diabetes, endocrinology and vaccine research, he is the founder of ‘Vaxine’, a company funded by the US - National Institutes of Health to develop novel vaccine technologies. In 2009 Vaxine won the amp innovation award at the Telstra business awards and Australia's coolest company award from Australian anthill magazine.
For more details Contact
OMICS Group Incorporation
2360 Corporate Circle
Suite 400, Henderson
NV 89074-7722, USA
Phone: +1- 888-843-8169
Toll Free: +1-800-216-6499
Email: editor(dot)imr(at)omicsonline(dot)net OR editor(dot)imr(at)omicsonline(dot)org